Accuray Inc. (ARAY) - Market Capitalization

Graphic logo of Accuray Inc. (ARAY)

Serving as a valuation tool, the Accuray Incorporated (ARAY) price chart, with a market capitalization of 0.01, illustrates the position of the radiation equipment manufacturer. The business remains vulnerable due to reductions in government healthcare spending and protracted deal cycles. The operating model relies on external contractors for component manufacturing and logistics. Meanwhile, profit growth is driven by service maintenance, which offsets the slow assembly pace of complex installations.

ARAY (accuray.com) Market Value history from 07/04/2022 to 11/12/2026
Product sample of Accuray Incorporated

The scale of operations for Accuray Incorporated is reflected in the company's current market capitalization on the GURU.Markets platform. This indicator aggregates the market value of all shares, measuring the total valuation of the business by investors. The trend of this metric reveals the efficiency of capital management, eliminating any illusion of stability during liquidity declines. For Accuray Incorporated (ARAY), long-term service contracts for CyberKnife robots provide a fundamental support for value. The final market consensus determines the investment attractiveness of the asset.

Competitors of Accuray Incorporated (ARAY)

Market Value BeiGene ONC|Market Value HALO|RevMed - Market Capitalization|AAPG - Market Capitalization|CGON (CG Oncology, Inc.) - Market Valuation|Market Value urogen.com (URGN)|BCAX (Bicara Therapeutics) - Market Capitalization|Market Valuation Personalis Inc (PSNL)|Market Capitalization ERAS|Market Capitalization Delcath Corp (DCTH)|Market Value Y-mAbs Therapeutics YMAB|AURA: Market Capitalization|Candel - Market Capitalization|SELLAS Life Sciences (SLS) - Market Valuation|ACTU: Market Capitalization|Market Value Citius Oncology Inc (CTOR)|Market Value TuHURA Biosciences Inc.|TARA: Market Value|Market Valuation FATE (Fate Therapeutics)|WHWK (aadibio.com) - Market Value|Market Capitalization TCRX (TScan Therapeutics, Inc.)|CSBR - Market Valuation|XBIT: Market Valuation|CVM - Market Capitalization|OS Therapies (OSTX) - Market Value|Radiopharm Theranostics Ltd - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Value Adlai Nortye Limited ANL|Market Capitalization VERU|Market Capitalization tempesttx.com (TPST)|Market Capitalization XLO (Xilio Therapeutics)|RENB - Market Valuation|Mural Bio - Market Capitalization|Kairos Pharma Ltd (KAPA) - Market Valuation|OKUR (onkuretherapeutics.com) - Market Valuation|CytoMed Therapeutics Limited (GDTC) - Market Capitalization|Market Value Curis Inc.|APLM: Market Value|Market Capitalization THAR|Market Capitalization advanbiomed.com (ADVB)|Genprex, Inc. - Market Valuation|Calidi Biotherapeutics Inc. (CLDI) - Market Value|SBFM: Market Valuation|Market Value XBIO (Xenetic Biosciences)|SLRX: Market Capitalization|PPBT - Market Capitalization|Market Value American Oncology Network Inc|Market Capitalization BGNE (beigene.com)|Market Capitalization CKPT|Market Valuation Elevation Oncology Inc. ELEV|Market Value iCAD ICAD|Ikena Oncology Inc. (IKNA) - Market Value|NTBL - Market Value|Market Value VIRX (Viracta Therapeutics)|MorphoSys (MOR) - Market Value|Market Valuation NAYA (NAYA Biosciences Inc)|Market Value Ascentage Pharma Group Ltd